Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Published:2012-12 Issue:12 Volume:7 Page:1830-1844
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Di Maio Massimo,Leighl Natasha B.,Gallo Ciro,Feld Ronald,Ciardiello Fortunato,Butts Charles,Maione Paolo,Gebbia Vittorio,Morgillo Floriana,Wierzbicki Rafal,Favaretto Adolfo,Alam Yasmin,Cinieri Saverio,Siena Salvatore,Bianco Roberto,Riccardi Ferdinando,Spatafora Mario,Ravaioli Alberto,Felletti Raffaella,Fregoni Vittorio,Genestreti Giovenzio,Rossi Antonio,Mancuso Gianfranco,Fasano Morena,Morabito Alessandro,Tsao Ming Sound,Signoriello Simona,Perrone Francesco,Gridelli Cesare

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials;NSCLC Meta-Analyses Collaborative Group;J Clin Oncol,2008

3. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

4. National Cancer Institute of Canada Clinical Trials Group Study BR.21. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21;Bezjak;J Clin Oncol,2006

5. Patient preferences for oral versus intravenous palliative chemotherapy;Liu;J Clin Oncol,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular RNA profiles in non-small cell lung cancer plasma;Journal of Thoracic Disease;2023-05

2. Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework;BMC Medical Research Methodology;2022-10-04

3. Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis;Future Oncology;2022-05

4. Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life;Advances in Therapy;2022-03-12

5. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer;Cochrane Database of Systematic Reviews;2021-03-18